Is it rational, reasonable or excessive, and consistently applied? One view of the increasing FDA emphasis on safety first for the release and use of antiarrhythmic drugs for supraventricular arrhythmias.
作者信息
Reiffel J A
机构信息
Electrophysiology Service, Division of Cardiology, Department of Medicine, Columbia University, College of Physicians & Surgeons, New York, USA.
出版信息
J Cardiovasc Pharmacol Ther. 2001 Oct;6(4):333-9. doi: 10.1177/107424840100600402.
PMID:11907635
Abstract
摘要
Zotero 插件